|
Protocol |
| 805884 |
|
Title |
| Study of FDA Approved Catheter used for the treatment of Ventricular Tachycardia |
|
Investigator |
| Francis Marchlinski, MD |
|
Status |
| No longer recruiting |
|
Why is this study being done? |
| To provide additional, corroborative safety data for an already FDA approved Catheter for treatment of patients with Ventricular Tachycardia (VT) associated with coronary artery disease. |
|
Who is eligible to participate in this study? |
Inclusion |
- over 18 years of age
- 4 or more documented episodes of spontaneous ventricular
tachycardia (VT) or incessant VT associated with coronary
artery disease. Episodes are documented by ECG, ICD
(implantable defibrillator / pacemaker) interrogation,
and/or telemetry strips
- failed treatment with medication
|
Exclusion |
- severe heart failure
- bleeding disorder: thrombocytopenia, clotting disorder
- MI (heart attack) or cardiac surgery within 2 months
- VT not associated with coronary artery disease
- unstable angina
- certain abnormalities found on echocardiogram
|
|
Age range? |
From: | 18 |
|
What is involved with this study? |
| Use of an already FDA approved catheter for treatment of VT.
Evaluations:
**echocardiogram before and after the procedure (standard practice)
**echocardiogram and follow up visit at 6 months
**Quality of life questionnaire before procedure and at 6 month visit
**annual progress check either at office visit or by phone for 3 years
|
|
How long will this study run? |
| There is no set end point. |
|
Who can I contact for additional information on this trial? |
Name: | Marty Sweeney, RN, RN, MS
|
Phone: | 215-615-0186 |
Email: | Martha.Sweeney@uphs.upenn.edu |
Name: | Mary Gnap, RN, RN, CCRC
|
Phone: | 215- 349-8446 |
Email: | Mary.Gnap@uphs.upenn.edu |
| Next Study |
